From: White paper on microbial anti-cancer therapy and prevention
Biological Agent | Virus | NCT# | Indication |
---|---|---|---|
TG6002 | Vaccinia virus | NCT03294486 | Glioblastoma |
ADV/HSV-tk | Adenovirus | NCT03004183 | NSCLC and triple-negative Breast Cancer |
Pexa-Vec | Vaccinia | NCT03206073 NCT02562755 | Colorectal Hepatocellular Carcinoma |
LOAd703 | Adenovirus | NCT02705196 | Pancreatic Cancer |
CG0070 | Adenovirus | NCT02365818 | Bladder cancer |
MV-NIS | Measles | NCT00408590 NCT02192775 | Ovarian cancer Multiple myeloma |
HF-10 | HSV-1 | NCT03252808 | Melanoma |
GL-ONC1 | Vaccinia virus | NCT02714374 NCT02759588 | Solid Tumors Ovarian cancer |
VCN-01 | Adenovirus | NCT02045602 | Advanced Solid Tumors |
Ad-MAGEA3 | Adenovirus | NCT02879760 | NSCLC |
OBP-301 | Adenovirus | NCT03190824 | Unresectable Metastatic Melanoma |
G207 | HSV-1 | NCT02457845 | Pediatric Brain Tumors |